nm23 gene polymorphisms are associated with survival of patients with epithelial ovarian cancer but not with susceptibility to disease

► Functional SNPs on nm23 gene promoter region maybe alter clinical outcome of epithelial ovarian cancer patients. ► The polymorphisms on nm23 gene may be biomarker for prognosis of patients but not for risk of developing ovarian cancer.